Cellular immune response to an engineered cell-based tumor vaccine at the vaccination site.

about

Examining T cells at vaccine sites of tumor-bearing hosts provides insights to dysfunctional T-cell immunity.Expression of macrophage migration inhibitory factor by neuroblastoma leads to the inhibition of antitumor T cell reactivity in vivo.

P2860

Q39232427-94967517-E0D3-417E-8DEC-7E533C83A2F2 Q42940126-5D5803A5-35BA-47F0-93AA-D5983772935D

P2860

Cellular immune response to an engineered cell-based tumor vaccine at the vaccination site.

Item

http://www.wikidata.org/entity/Q40125045

description

2007 nî lūn-bûn

@nan

2007年の論文

@ja

2007年論文

@yue

2007年論文

@zh-hant

2007年論文

@zh-hk

2007年論文

@zh-mo

2007年論文

@zh-tw

2007年论文

@wuu

2007年论文

@zh

2007年论文

@zh-cn

name

Cellular immune response to an ...... ccine at the vaccination site.

@en

type

Item

label

Cellular immune response to an ...... ccine at the vaccination site.

@en

prefLabel

Cellular immune response to an ...... ccine at the vaccination site.

@en

P1476

Cellular immune response to an ...... ccine at the vaccination site.

@en

P2093

Bryon D Johnson

http://www.w3.org/2001/XMLSchema#string

Qiang Zhou

http://www.w3.org/2001/XMLSchema#string

Rimas J Orentas

http://www.w3.org/2001/XMLSchema#string

P2860

A chemokine expressed in lymphoid high endothelial venules promotes the adhesion and chemotaxis of naive T lymphocytes

CD137 induces proliferation and endomitosis in monocytes

Two subsets of memory T lymphocytes with distinct homing potentials and effector functions

Cutting edge: Expression of functional CD137 receptor by dendritic cells

The B7 family revisited

Integrin alpha(2)beta(1) (VLA-2) is a principal receptor used by neutrophils for locomotion in extravascular tissue

Cytokine storm in a phase 1 trial of the anti-CD28 monoclonal antibody TGN1412

Treatment of high-risk neuroblastoma with intensive chemotherapy, radiotherapy, autologous bone marrow transplantation, and 13-cis-retinoic acid. Children's Cancer Group.

The human integrin VLA-2 is a collagen receptor on some cells and a collagen/laminin receptor on others.

Provision of antigen and CD137 signaling breaks immunological ignorance, promoting regression of poorly immunogenic tumors.

P304

91-102

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.CELLIMM.2007.04.004

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

245

http://www.w3.org/2001/XMLSchema#string

P577

2007-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6292373

http://www.w3.org/2001/XMLSchema#string

P698

17543914

http://www.w3.org/2001/XMLSchema#string

P932

1949498

http://www.w3.org/2001/XMLSchema#string

Cellular immune response to an engineered cell-based tumor vaccine at the vaccination site.

about

P2860

P2860

Cellular immune response to an engineered cell-based tumor vaccine at the vaccination site.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P698

P932